EudraLex - Volume 6
|
|||||||||||||||||||||||
Volume 6 of the publications “The rules governing medicinal products in the European Union” contains a list of regulatory guidelines related to procedural and regulatory requirements such as renewal procedures, dossier requirements for Type IA/IB variation notifications, summary of product characteristics (SPC), package information and classification for the supply, readability of the label and package leaflet requirements. |
|||||||||||||||||||||||
On this page :
Volume 6A dealing with procedures for marketing authorisation; Volume 6B dealing with the presentation and content of the application dossier. |
|||||||||||||||||||||||
Volume 6A - Procedures for marketing authorisation |
|||||||||||||||||||||||
January 2007 |
|||||||||||||||||||||||
November 2005 |
|||||||||||||||||||||||
September 2007 |
|||||||||||||||||||||||
May 2006 |
|||||||||||||||||||||||
February 2010 - Procedural note concerning the Guideline on the operation of the procedures laid down in chapters II, III, and IV of commission regulation (ec) 1234/2008 of concerning the examination of variations to the Terms of Marketing Authorisations for Medicinal Products for human use and veterinary medicinal products (March 2011) |
|
||||||||||||||||||||||
November 2005 |
|||||||||||||||||||||||
February 2010 |
|||||||||||||||||||||||
Volume 6B Notice to applicants Veterinary medicinal products Presentation and contents of the dossier - March 2004 |
|||||||||||||||||||||||
PART I - Summary of the dossier / Administrative data 1A - Revision 7.2 - 0ctober 2008 : PDF - Word Format |
|||||||||||||||||||||||
Guidelines on Summary of product Characteristics |
|
||||||||||||||||||||||
- Guideline on preparation of Summary of Product Characteristics SPC - Pharmaceuticals for veterinary medicinal products - revision 2 July /2006 |
|||||||||||||||||||||||
- Guideline on preparation of Summary of Product Characteristics SPC - Immunologicals for veterinary medicinal products - revision 3 June 2007 |
|||||||||||||||||||||||
- Guideline on the processing of renewals in the mutual recognition procedure for veterinary medicinal products - revision February 2006 |
|||||||||||||||||||||||
- Guideline on the processing of renewals in the centralised procedure - December 2005) |
|||||||||||||||||||||||
- Application form for renewal of a marketing authorisation and guidance for the completion of the application form - February 2007 |
|||||||||||||||||||||||
- Guideline on Dossier requirements for Type IA and Type IB Notifications - Revision 1 June 2006 |
|||||||||||||||||||||||
Application form for variation to a marketing authorisation for medicinal products (human and veterinary) to be used in the mutual recognition and the centralised procedure - December 2009. |
|||||||||||||||||||||||
- Guideline on the categorisation of New Applications (NA) versus Variations Applications (V) - October 2003 |
|||||||||||||||||||||||
- Guideline on the details of the various categories of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (2010/C 17/01) - Word format en [2 MB] - February 2010 |
|
||||||||||||||||||||||
- Guideline on the packaging information of veterinary medicinal products authorised by the Community - (blue box) - January 2008 |
|||||||||||||||||||||||
- Guidance on the Assessment of environmental risks of veterinary medicinal products - June 2009 |
|||||||||||||||||||||||
- Guidance on environmental risk assessment for veterinary medicinal products consisting of or containing genetically modified organisms (GMOs) as or in products - March 2006 |
|||||||||||||||||||||||
- Guideline on the definition of a potential serious risk to human or animal health or for the environment in the context of Article 33(1) and (2) of Directive 2001/82/EC (Official Journal C 132, 7/6/2006 p. 32 - 35) |
|
||||||||||||||||||||||
|
|||||||||||||||||||||||
For further explanations, see volume 2B - (Human) |
|||||||||||||||||||||||